Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma
Clinical trial NCT00795665 · COMPLETED
Trial details
- NCT number
- NCT00795665
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.